Top-line results were announced by Pfizer of a double-blind, Phase III study evaluating pregabalin controlled-release (CR) formulation in patients with...
Pfizer has announced top-line results of a Phase III study evaluating the efficacy and safety of Lyrica (pregabalin) Capsules CV...
Pfizer’s Lyrica (pregabalin/pregabalin controlled release) confronts questions of safety after a study published in Neurology reported a possible link between...
Pfizer will not proceed with regulatory approval for Lyrica (pregabalin), its GABA analogue, for Restless Legs Syndrome despite reporting positive...
Pfizer announced top-line results for Lyrica (pregabalin) capsules Study A0081147 � Long Term Safety and Efficacy of Pregabalin in Subjects...
Pfizer has announced top-line results from a double-blind Phase III study evaluating Lyrica (pregabalin controlled-release CR) formulation in adult patients...
A Phase III clinical trial of Lyrica (pregabalin), from Pfizer, in patients with Neuropathic Pain associated with HIV neuropathy has...
The FDA has approved the use of Lyrica (pregabalin) capsules CV from Pfizer for the management of Neuropathic Pain associated...
Pfizer Inc. announced top-line results of a double-blind Phase IV study evaluating the safety and efficacy of Lyrica (pregabalin) Capsules...
Top-line results are reported by Pfizer for a Phase III study that showed Lyrica (pregabalin) Capsules CV were as effective...